Paratus Clinical

Are you interested in participating in clinical trials?

Register your interest, and we'll notify you of any upcoming trials that might be suitable for you.
We value your privacy and are committed to protecting your data and personal information.

For clinical trials, time is money

The faster a new vaccine or drug gets to market, the sooner it starts providing health benefits. Undertaking clinical trials needs to strike the right balance between speed to trial and quality of outcomes. To achieve this, efficient participant recruitment is key.

We have a team of dedicated recruitment specialists based at each clinic, strong community outreach and large participant databases to ensure fast and effective study recruitment.

Paratus Clinical operates four research-only clinics in population-dense locations with easy access to transport, medical and allied health professionals.

Since our inception, we have been awarded 50 clinical trials by pharmaceutical companies, contract research organisations (CROs), biotechnology companies, medical device companies and academic research institutions.

Why choose Paratus Clinical?

1.

Ensured Quality

2.

Trained and Experienced Staff

3.

Fast Setup

4

Committed Patient Recruitment Team

The Paratus Clinical difference

AVERAGE 38 BUSINESS DAYS

To complete regulatory processes.

INDUSTRY STANDARD:

Average 60 days

FREQUENT AND TIMELY HREC SUBMISSIONS

Assigned HREC officer completes all processes.

INDUSTRY STANDARD:

Infrequent HREC meetings, often conducted by study coordinator.

GOVERNANCE COMPLETED IN PARALLEL

Expediting startup timelines.

INDUSTRY STANDARD:

Possible governance delays.

Featured clinical trials

Now recruiting

Central-Coast

Actively recruiting participants

Cytomegalovirus Vaccine Study

This Phase 3, randomised, placebo-controlled, observer-blind clinical trial is designed to evaluate the safety, efficacy and immunogenicity of an investigational vaccine (mRNA-1647) for CMV in healthy volunteers.

Canberra

Actively recruiting participants

Cytomegalovirus Vaccine Study

This Phase 3, randomised, placebo-controlled, observer-blind clinical trial is designed to evaluate the safety, efficacy and immunogenicity of an investigational vaccine (mRNA-1647) for CMV in healthy volunteers.

Western-Sydney

Actively recruiting participants

Cytomegalovirus Vaccine Study

This Phase 3, randomised, placebo-controlled, observer-blind clinical trial is designed to evaluate the safety, efficacy and immunogenicity of an investigational vaccine (mRNA-1647) for CMV in healthy volunteers.

Western-Sydney

Actively recruiting participants

Broad-Spectrum Influenza Vaccine Study

This phase 2a study is testing the safety, immunogenicity and reactogenicity of concomitant administration of a new broad-spectrum influenza vaccine (OVX836) with quadrivalent inactivated influenza virus (QIV) vaccines in healthy volunteers.

Brisbane

Actively recruiting participants

Broad-Spectrum Influenza Vaccine Study

This phase 2a study is testing the safety, immunogenicity and reactogenicity of concomitant administration of a new broad-spectrum influenza vaccine (OVX836) with quadrivalent inactivated influenza virus (QIV) vaccines in healthy volunteers.

Central-Coast

Actively recruiting participants

Broad-Spectrum Influenza Vaccine Study

This phase 2a study is testing the safety, immunogenicity and reactogenicity of concomitant administration of a new broad-spectrum influenza vaccine (OVX836) with quadrivalent inactivated influenza virus (QIV) vaccines in healthy volunteers.

Canberra

Actively recruiting participants

CBD treatment for Pain Study

A Randomised, Double-Blind, Placebo-Controlled, Parallel-Arm Study to Evaluate the Efficacy, Safety and Tolerability of 150 mg Sublingual Cannabidiol in Adults with Mild-to-Moderate Pain.

Western-Sydney

Actively recruiting participants

CBD treatment for Pain Study

A Randomised, Double-Blind, Placebo-Controlled, Parallel-Arm Study to Evaluate the Efficacy, Safety and Tolerability of 150 mg Sublingual Cannabidiol in Adults with Mild-to-Moderate Pain.

Central-Coast

Actively recruiting participants

CBD treatment for Pain Study

A Randomised, Double-Blind, Placebo-Controlled, Parallel-Arm Study to Evaluate the Efficacy, Safety and Tolerability of 150 mg Sublingual Cannabidiol in Adults with Mild-to-Moderate Pain.

Brisbane

Actively recruiting participants

CBD treatment for Pain Study

A Randomised, Double-Blind, Placebo-Controlled, Parallel-Arm Study to Evaluate the Efficacy, Safety and Tolerability of 150 mg Sublingual Cannabidiol in Adults with Mild-to-Moderate Pain.

Brisbane

Actively recruiting participants

COVID-19 Booster Vaccine

This study aims to evaluate the immunogenicity and safety of ChulaCov19 BNA159 Vaccine as a Booster Dose.

COVID-19 Booster Vaccine

This study aims to evaluate the immunogenicity and safety of ChulaCov19 BNA159 Vaccine as a Booster Dose.

Locations

Each of our research clinics has been carefully located in highly-populated areas with easy access to medical and allied health professionals, as well as tertiary hospitals. All sites are fully staffed, have OTGR-accredited PC1 facilities and the latest commercial grade technology and equipment.

Better recruitment means faster outcomes.

Efficient recruitment of the right participants is key to conducting a successful clinical trial. Paratus Clinical has invested in dedicated recruitment specialists at head office and at each clinical site to meet our goal of exceeding recruitment targets for every clinical trial.

Our focus on recruitment delivers better trial outcomes including decreased patient dropouts, and phone-based pre-screening reduces screening failures.

Strong relationships within local communities around our clinical sites provides increased awareness of research and helps deliver a consistent flow of relevant trial participants.

The people behind Paratus Clinical

Great people help deliver successful clinical trials. At Paratus Clinical we have built a formidable and experienced team at our head office and on the ground at all our clinical sites.

Each clinical site has the following key staff members on-site to manage, research, administer and recruit for client trials:

SITE MANAGER

Oversees all site operations

PRINCIPAL INVESTIGATOR

Provides medical oversight for all trials conducted on-site.

SUB-INVESTIGATOR

Supports the principal investigator

CLINICAL RESEARCH COORDINATOR

Main point of client contact and manages delivery of trials.

CLINICAL RESEARCH NURSE

Performs duties including vaccination, phlebotomy, vitals and other important measurements.

RESEARCH RECRUITMENT SPECIALIST

Conducts site-based recruitment activity.

Get in touch

Would you like to talk to us about an upcoming clinical trial, or to find out more about what we do?

Are you interested in participating in one of our upcoming clinical trials?

Paratus Clinical is proud to be a Society for Clinical Research Sites member. We actively participate in discussions and decisions that ultimately impact the industry at large. Being a part of the SCRS community gives us the opportunity to be heard and allows us to partake in industry training and events.
Navigation
- About
- Participate
- Trials
- Articles
- News
Locations
T: 1300 742 326